John M. Goldman
John M. Goldman (30 November 1938 – 24 December 2013) was a British haematologist, oncologist and medical researcher. A specialist in chronic myeloid leukaemia, Goldman conducted pioneering research into leukaemia treatment – he was instrumental in the development of bone marrow transplantation as a clinical method, and later in the development of the drug imatinib. He was also a prolific author of scientific papers, was involved with numerous medical charities and had a decades-long surgical career at Hammersmith Hospital, London.
Wikipage disambiguates
primaryTopic
John M. Goldman
John M. Goldman (30 November 1938 – 24 December 2013) was a British haematologist, oncologist and medical researcher. A specialist in chronic myeloid leukaemia, Goldman conducted pioneering research into leukaemia treatment – he was instrumental in the development of bone marrow transplantation as a clinical method, and later in the development of the drug imatinib. He was also a prolific author of scientific papers, was involved with numerous medical charities and had a decades-long surgical career at Hammersmith Hospital, London.
has abstract
John M. Goldman (30 November 1 ...... Hammersmith Hospital, London.
@en
birth date
1938-11-30
birth year
death date
2013-12-24
death year
Link from a Wikipage to an external page
Wikipage page ID
41,985,765
page length (characters) of wiki page
Wikipage revision ID
1,006,485,226
Link from a Wikipage to another Wikipage
birth date
1938-11-30
birth place
London
@en
death date
2013-12-24
known for
@en
Development of new treatments for leukaemia
@en
Pioneering work in bone marrow transplantation
@en
name
John M. Goldman
@en
occupation
@en
Haematologist
@en
oncologist
@en
wikiPageUsesTemplate
subject
hypernym
sameAs
comment
John M. Goldman (30 November 1 ...... Hammersmith Hospital, London.
@en
label
John M. Goldman
@en
sameAs
wasDerivedFrom
isPrimaryTopicOf
name
John M. Goldman
@en